UNSPSC 51452603: Febantel for veterinary use

This classification denotes an antihelminthic agent with the molecular formula C20H22N4O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S75C401OS1, chemically known as n-(2-(2,3-bis-(methoxycarbonyl)-guanidino)-5-(phenylthio)-phenyl)-2-methoxyacetamide but more generally known as febantel, which bears US NIH Compound Identifier 9570638. European Medicines Agency schedules Febantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07518MIG.

UNSPSC 51452603 Febantel for veterinary use, a Commodity code, shows little relevant recent activity aligned with its nominal scope. The four most recent opportunities tagged under this code involve human health-care products and pharmaceuticals—naloxone and drug deactivation systems for Seminole County, Florida; a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs; medical and first aid supplies for the Tampa Fire Department Rescue Division; and a Minnesota Multistate Cooperative Purchasing Alliance RFP for generic multi-source pharmaceuticals and OTC products. None of these solicitations involve veterinary pharmaceuticals or febantel specifically. The mismatch suggests that state and local procurement systems have misclassified these opportunities under a code intended for animal health products, or that the code assignment reflects a broader pharmaceutical or OTC product category that encompasses human-health procurement as well as veterinary supplies.

State and local governments procuring under this nominal code span health departments and human services agencies (Seminole County Community Health, Texas HHS Commission), municipal fire and rescue departments (City of Tampa), and multi-state cooperative purchasing consortia (Minnesota MMCAP serving state and local facilities across multiple states including Oregon). The geographic spread includes Florida, Texas, and Minnesota-based initiatives. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems with a response date of July 26, 2023 (note: this date predates the posting date listed in the source and may reflect a data error); the City of Tampa's IFB for medical and first aid supplies with a March 13, 2026 deadline and an estimated contract value of $700,000 designated for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota MMCAP RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 proposal deadline. Because the code does not reflect actual veterinary pharmaceutical procurement, business development professionals should verify code assignment before pursuing opportunities listed under 51452603.